Neurological complications of essential thrombocytosis (ET)

Acta Neurologica Scandinavica

Volumn 102, Issue 5, 2000, Pages 299-302

  Kesler, A ^a,b   Ellis, M H ^a   Manor, Y ^a   Gadoth, N ^a   Lishner, M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

Author keywords

Essential thrombocytosis; Neurological

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPILEPSY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONEUROPATHY MULTIPLEX; NEUROLOGIC DISEASE; OCCLUSIVE CEREBROVASCULAR DISEASE; POLYCYTHEMIA VERA; RISK FACTOR; THROMBOCYTOSIS; VEIN THROMBOSIS; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HEADACHE; HUMANS; ISRAEL; MALE; MEDICAL RECORDS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PARESTHESIA; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEIZURES; SEX DISTRIBUTION; THROMBOCYTOSIS; VISION DISORDERS;

EID: 0033774301     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2000.102005299.x     Document Type: Article

References (14)

1. Primary thrombocythemia
2. Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms
3. Essential thrombocythemia: Clinical characteristics and course of 61 cases
4. Thrombosis and hemorrhage in thrombocytosis: Evaluation of a large cohort of patients
5. Essential thrombocythemia and central retinal vein occlusion with neovascular glaucoma
6. Issues in the diagnosis and management of essential thrombocytosis
7. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment
8. Cerebral manifestations in thrombocythemia
9. Idiopathic thrombocythosis: A treatable cause of transient ischemic attacks
10. Neurologic syndromes associated with primary thrombocythemia
11. Neurologic manifestations of essential thrombocytosis
12. Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders: A retrospective analysis of 26 patients
13. Management of thrombocythemia
14. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis